The company
Collegium Pharmaceutical, Inc.
COLL · Nasdaq
COLL stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 25.4% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 33
- Industry in uptrend
- 31% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $10.6M
- Officials’ trades on record
- 4
- Institutions holding
- 258 (+12)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
4 disclosed lines: House 0, Senate 0, executive 4; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 8 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 30 Apr 2026filed 1 Jul 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| John Gordon FreundDirector | sold | 20at $34.05 | 18 May 2026filed 20 May 2026 |
| John Gordon FreundDirector | sold | 4,127at $34.54 | 15 May 2026filed 18 May 2026 |
| Nancy LurkerDirector | sold | 4,500at $35.97 | 13 May 2026filed 15 May 2026 |
| Garen G. BohlinDirector | sold | 8,700at $37.18 | 11 May 2026filed 13 May 2026 |
| David DieterEVP & General Counsel | sold | 13,976at $34.92 | 18 Mar 2026filed 20 Mar 2026 |
| David DieterEVP & General Counsel | sold | 6,224at $36.65 | 9 Mar 2026filed 11 Mar 2026 |
| Scott DreyerEVP & Chief Commercial Officer | sold | 46,417at $40.36 | 3 Mar 2026filed 5 Mar 2026 |
| Scott DreyerEVP & Chief Commercial Officer | sold | 3,559at $40.99 | 3 Mar 2026filed 5 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 5,441,202$197.0M | +307,175+6.0% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 2,147,072$77.7M | +2,147,072 |
| Invesco Ltd.added · filed 14 Aug 2026 | 1,882,499$68.1M | +290,590+18.3% |
| FULLER & THALER ASSET MANAGEMENT, INC.added · filed 12 Aug 2026 | 1,632,781$59.1M | +133,197+8.9% |
| PRINCIPAL FINANCIAL GROUP INCadded · filed 4 Aug 2026 | 1,632,360$59.1M | +337,332+26.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 1,528,881$55.3M | +104,337+7.3% |
| MASSACHUSETTS FINANCIAL SERVICES COadded · filed 3 Aug 2026 | 1,405,567$50.9M | +39,635+2.9% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,381,261$50.0M | +47,269+3.5% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 1,366,549$49.5M | -102,900−7.0% |
| EVENTIDE ASSET MANAGEMENT, LLCreduced · filed 14 Aug 2026 | 1,361,228$49.3M | -63,054−4.4% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.